Literature DB >> 21669283

Upregulation of select rab GTPases in cholinergic basal forebrain neurons in mild cognitive impairment and Alzheimer's disease.

Stephen D Ginsberg1, Elliott J Mufson, Melissa J Alldred, Scott E Counts, Joanne Wuu, Ralph A Nixon, Shaoli Che.   

Abstract

Endocytic system dysfunction is one of the earliest disturbances that occur in Alzheimer's disease (AD), and may underlie the selective vulnerability of cholinergic basal forebrain (CBF) neurons during the progression of dementia. Herein we report that genes regulating early and late endosomes are selectively upregulated within CBF neurons in mild cognitive impairment (MCI) and AD. Specifically, upregulation of rab4, rab5, rab7, and rab27 was observed in CBF neurons microdissected from postmortem brains of individuals with MCI and AD compared to age-matched control subjects with no cognitive impairment (NCI). Upregulated expression of rab4, rab5, rab7, and rab27 correlated with antemortem measures of cognitive decline in individuals with MCI and AD. qPCR validated upregulation of these select rab GTPases within microdissected samples of the basal forebrain. Moreover, quantitative immunoblot analysis demonstrated upregulation of rab5 protein expression in the basal forebrain of subjects with MCI and AD. The elevation of rab4, rab5, and rab7 expression is consistent with our recent observations in CA1 pyramidal neurons in MCI and AD. These findings provide further support that endosomal pathology accelerates endocytosis and endosome recycling, which may promote aberrant endosomal signaling and neurodegeneration throughout the progression of AD.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21669283      PMCID: PMC3163754          DOI: 10.1016/j.jchemneu.2011.05.012

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  93 in total

Review 1.  The endosomal-lysosomal system of neurons in Alzheimer's disease pathogenesis: a review.

Authors:  R A Nixon; A M Cataldo; P M Mathews
Journal:  Neurochem Res       Date:  2000-10       Impact factor: 3.996

Review 2.  Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases.

Authors:  Jennifer L Seachrist; Stephen S G Ferguson
Journal:  Life Sci       Date:  2003-12-05       Impact factor: 5.037

Review 3.  Cholinergic system during the progression of Alzheimer's disease: therapeutic implications.

Authors:  Elliott J Mufson; Scott E Counts; Sylvia E Perez; Stephen D Ginsberg
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

4.  Transcriptional profiling of small samples in the central nervous system.

Authors:  Stephen D Ginsberg
Journal:  Methods Mol Biol       Date:  2008

5.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

Review 6.  The endosomal-lysosomal system of neurons: new roles.

Authors:  R A Nixon; A M Cataldo
Journal:  Trends Neurosci       Date:  1995-11       Impact factor: 13.837

Review 7.  Brain immune responses cognitive decline and dementia: relationship with phenotype expression and genetic background.

Authors:  Federico Licastro; Martina Chiappelli
Journal:  Mech Ageing Dev       Date:  2003-04       Impact factor: 5.432

8.  Endocytic disturbances distinguish among subtypes of Alzheimer's disease and related disorders.

Authors:  A Cataldo; G W Rebeck; B Ghetri; C Hulette; C Lippa; C Van Broeckhoven; C van Duijn; P Cras; N Bogdanovic; T Bird; C Peterhoff; R Nixon
Journal:  Ann Neurol       Date:  2001-11       Impact factor: 10.422

9.  Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.

Authors:  Steven T DeKosky; Milos D Ikonomovic; Scot D Styren; Laurel Beckett; Stephen Wisniewski; David A Bennett; Elizabeth J Cochran; Jeffrey H Kordower; Elliott J Mufson
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

Review 10.  Functional genomic methodologies.

Authors:  Stephen D Ginsberg; Károly Mirnics
Journal:  Prog Brain Res       Date:  2006       Impact factor: 2.453

View more
  62 in total

1.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

2.  Expression profiling of precuneus layer III cathepsin D-immunopositive pyramidal neurons in mild cognitive impairment and Alzheimer's disease: Evidence for neuronal signaling vulnerability.

Authors:  Bin He; Sylvia E Perez; Sang H Lee; Stephen D Ginsberg; Michael Malek-Ahmadi; Elliott J Mufson
Journal:  J Comp Neurol       Date:  2020-05-05       Impact factor: 3.215

3.  The GTPase Rab27b regulates the release, autophagic clearance, and toxicity of α-synuclein.

Authors:  Rachel Underwood; Bing Wang; Christine Carico; Robert H Whitaker; William J Placzek; Talene A Yacoubian
Journal:  J Biol Chem       Date:  2020-04-29       Impact factor: 5.157

Review 4.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

5.  Brain-derived neurotrophic factor (BDNF) and TrkB hippocampal gene expression are putative predictors of neuritic plaque and neurofibrillary tangle pathology.

Authors:  Stephen D Ginsberg; Michael H Malek-Ahmadi; Melissa J Alldred; Yinghua Chen; Kewei Chen; Moses V Chao; Scott E Counts; Elliott J Mufson
Journal:  Neurobiol Dis       Date:  2019-07-23       Impact factor: 5.996

6.  Targeted Quantitative Proteomic Approach for High-Throughput Quantitative Profiling of Small GTPases in Brain Tissues of Alzheimer's Disease Patients.

Authors:  Ming Huang; Martin Darvas; C Dirk Keene; Yinsheng Wang
Journal:  Anal Chem       Date:  2019-09-10       Impact factor: 6.986

7.  Protein homeostasis gene dysregulation in pretangle-bearing nucleus basalis neurons during the progression of Alzheimer's disease.

Authors:  Chelsea T Tiernan; Stephen D Ginsberg; Angela L Guillozet-Bongaarts; Sarah M Ward; Bin He; Nicholas M Kanaan; Elliott J Mufson; Lester I Binder; Scott E Counts
Journal:  Neurobiol Aging       Date:  2016-03-08       Impact factor: 4.673

8.  Maternal Choline Supplementation Alters Basal Forebrain Cholinergic Neuron Gene Expression in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Christy M Kelley; Stephen D Ginsberg; Melissa J Alldred; Barbara J Strupp; Elliott J Mufson
Journal:  Dev Neurobiol       Date:  2019-06-09       Impact factor: 3.964

9.  Clearance of intracellular tau protein from neuronal cells via VAMP8-induced secretion.

Authors:  Julie Pilliod; Alexandre Desjardins; Camille Pernègre; Hélène Jamann; Catherine Larochelle; Edward A Fon; Nicole Leclerc
Journal:  J Biol Chem       Date:  2020-10-22       Impact factor: 5.157

10.  Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-β protein precursor transgenic mice.

Authors:  Jennifer H K Choi; Gurjinder Kaur; Matthew J Mazzella; Jose Morales-Corraliza; Efrat Levy; Paul M Mathews
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.